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Abstract.  An important question regarding  autocrine 
transformation  by v-sis is whether intracellularly  acti- 
vated PDGF receptors are sufficient to transform cells 
or whether activated receptor-ligand complexes are re- 
quired at the cell surface. We have addressed this ques- 
tion by inhibiting cell surface transport of a membrane- 
anchored v-sis protein utilizing the ER retention signal 
of the adenoviral transmembrane  protein E3/19K.  A 
v-sis fusion protein containing this  signal was retained 
within the cell and not transported  to the cell surface 
as confirmed by immunofluorescent localization experi- 
ments.  Also, proteolytic maturation of this protein was 
suppressed,  indicating  inefficient transport to post- 
Golgi compartments  of the secretory pathway.  When 
compared with v-sis proteins lacking a functional reten- 
tion signal,  the ER-retained protein showed a dimin- 
ished ability to transform NIH 3T3  cells, as measured 
by the number and size of foci formed. In newly estab- 
lished cell lines, the ER-retained protein did not down- 
regulate PDGF receptors. However, continued passage of 
these cells selected for a fully transformed phenotype ex- 
hibiting downregulated PDGF receptors and proteolyti- 
cally processed v-sis protein. These results indicate that 
productive autocrine interactions occur in a post-ER com- 
partment of  the secretory pathway. Transport of v-sis pro- 
tein beyond the Golgi correlated with acquisition of  the 
transformed phenotype. Furthermore, suramin treatment 
reversed transformation and upregulated the expression of 
cell surface PDGF receptors, suggesting an important 
role for receptor-ligand  complexes localized to the 
cell surface. 
T 
HE study of growth  factors  and growth factor recep- 
tors has led to a better understanding  of the processes 
involved in the regulation of normal cell proliferation. 
Aberrant expression of such proteins is implicated in altered 
patterns of cell growth which can lead to cellular transforma- 
tion  and tumorigenesis  (for reviews  see Aaronson,  1991; 
Yarden and Ullrich,  1988; Deuel, 1987). The v-sis oncogene 
encodes the transforming  protein of simian  sarcoma virus 
(SSV) t,  an  acutely transforming  retrovirus  originally  iso- 
lated  from a woolly monkey fibrosarcoma (Theilen  et al., 
1971; Devare et al., 1983). Sequence analysis indicated that 
v-sis encodes a protein structurally related to the B chain of 
platelet-derived  growth  factor  (PDGF),  thus  indicating  a 
role for this growth factor in tumorigenesis (Doolittle et al., 
1983; Waterfield et al., 1983; Johnsson et al., 1984; Josephs 
et al., 1984). Only cells which express PDGF receptors can 
be transformed by v-sis,  supporting  a role for an autocrine 
loop in v-sis transformation  (Deuel et al.,  1983; Garret et 
al.,  1984; Huang et al.,  1984; Leal et al.,  1985). 
There has been some controversy as to where autocrine in- 
teractions take place between v-sis protein and PDGF recep- 
1. Abbreviations  used in this paper:  CSF-1, macrophage colony stimulating 
factor;  CS, calf serum;  M-MuLV, Molony murine leukemia virus;  SCE 
stem cell factor;  SSV, simian sarcoma virus; VSV G, vesicular stomatitis 
virus glycoprotein. 
tors in v-sis-transformed cells.  Antibodies directed against 
PDGF have been shown to inhibit  both transformation  and 
the  incorporation  of [3H]thymidine  into  some SSV-trans- 
formed cells, suggesting the importance of an extracellular 
site  of interaction  (Huang  et  al.,  1984;  Johnsson  et al., 
1985). However, in some cases v-sis protein was not detect- 
ably secreted and such transformed  cells were not affected 
by antibody addition (Huang et al., 184), indicating the pos- 
sibility  of intracellular  interaction  sites.  The possibility of 
important intracellular  interactions  has also been supported 
by the observation that continuous growth of nontransformed 
cells  in the presence of v-sis or c-sis protein does not re- 
sult  in cellular transformation  (Huang and  Huang,  1988). 
Others, however, have claimed no phenotypic difference be- 
tween  v-sis  transformed  cells  and  nontransformed  cells 
treated externally with PDGF (Johnsson et al., 1986; Flem- 
ing et al., 1989), again supporting an extracellular  site of in- 
teraction. 
Since both the v-sis protein and PDGF receptors are syn- 
thesized through the secretory pathway of cells, the potential 
exists for growth factor-receptor interactions  within various 
compartments of the ER and Golgi, as well as at the cell sur- 
face. Indeed, intracellular  interactions,  as detected by imma- 
ture receptor autophosphorylation,  have been observed in 
both SSV-transformed  cells (Keating  and  Williams,  1988; 
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v-sis protein  (Hannink and Donoghue,  1988). Rapid turn- 
over of  both v-sis protein and PDGF receptors was also noted 
in SSV-transformed cells and the majority of newly synthe- 
sized receptors in these cells failed to reach the cell surface 
(Keating  and  Williams,  1988; Huang  and  Huang,  1988; 
Lokeshwar et al., 1990), Thus, it seems quite apparent that 
PDGF  receptors  can  and do interact intracellularly  with 
v-sis protein.  An important question remains,  however, as 
to  whether intracellularly  activated  PDGF  receptors  are 
sufficient to transform  cells,  or whether activated  recep- 
tor-ligand complexes are required at the cell surface. This 
latter  possibility  encompasses  two distinct models.  In the 
first model, activated complexes may reach the cell surface 
after intracellular  formation  and subsequent  cell  surface 
transport.  In the second model, cell surface transport may 
occur separately for both growth factor and receptor,  after 
which point receptor-ligand complexes form leading to sig- 
nal transduction.  There is evidence supporting a model by 
which  receptors  are  activated internally,  but where  mito- 
genic signalling requires the cell surface localization of  these 
activated receptors  (Fleming et al.,  1989). 
To further examine the question of where productive re- 
ceptor-ligand interactions occur, a membrane-anchor  form 
of the v-sis protein (Hannink and Donoghue, 1986a) was lo- 
calized to the ER using the retention signal previously de- 
scribed  for the adenoviral transmembrane  protein  E3/19K 
(Nilssan et al., 1989). This signal can function to retain het- 
erologous transmembrane proteins such as human CD4 and 
CD8 within the ER. It should be noted that the E3/19K reten- 
tion signal differs from the KDEL retention signal described 
for luminal  ER proteins  (Munro  and Pelham,  1987). The 
KDEL signal presumably  interacts  with cellular  retention 
machinery on the luminal side of the ER, while the E3/19K 
retention signal functions on the cytoplasmic side of  the ER. 
In this report, we demonstrate that cellular transformation 
is inhibited by ER retention of a membrane-anchored  v-sis 
fusion protein. We also demonstrate that transport of  this fu- 
sion protein beyond the ER and into the trans-Golgi network 
correlates with downregulation of cell surface PDGF recep- 
tors and acquisition of the transformed phenotype. 
Materials and Methods 
Cell Culture and Antibody Reagents 
NIH 3T3 cells and their derivatives were cultured at 37~  in DME contain- 
ing 10% calf serum (CS) in a humidified 10% CO2 incubator. Cells were 
passaged  every 4  d  in culture.  Goat antiserum directed against human 
PDGF-AB and rabbit antiserum directed against the human PDGF/3 recep- 
tor were purchased from Upstate Biotechnology  Inc.  (Lake Placid, NY). 
The human PDGF ~5 receptor antibody cross reacts with murine PDGF 
/3 receptors. Rabbit antiserum directed against bacterially synthesized v-sis 
protein was generously provided by Ray Sween and Keith Deen (Smith, 
Kline, and French, King of Prussia, PA). Rabbit antiserum directed against 
the routine PDGF ~ receptor was kindly provided by Jung Huang (St. Louis 
University School of Medicine) (Huang and Huang,  1988).  The mouse 
mAb P5IM (Kreis and Lodish, 1986) directed against the COOH terminus 
of the vesicular stomatitis virus glycoprotein  (VSV G) was made available 
by William Balch (Scripps Clinic and Research Foundation, La Jolla, CA). 
Construction of v-sis Fusions 
The v-sls239-G gene, which encodes a  fusion betv~,en v-sis and VSV G 
(Hannink and Donoghue, 1986a),  was used as the parental clone to con- 
struct the v-sis fusions described in this report. Polymerase chain reaction 
(PCR) was utilized to fuse sequences encoding a functional (DEKKMP) or 
nonfunctional (DEMPKK) ER retention signal (Nilsson et at.,  1989) onto 
the 3' end of the v-sis2S9-G gene. Three oligonncleotides were synthesized 
to amplify a DNA fragment between the v-sis/VSV G junction and the 3' 
end of the VSV G geue (,~190 bp). One oligonncleotide encompassed se- 
quences surrounding the junction region between v-sis and the VSV G geue. 
This junction occurs at the BstEII site, nt 929, of v-sis (Devare et al., 1982) 
and an AiuI site, nt 1418 ofVSV G (Rose and Gallioue,  1981), just upstream 
of sequences encoding the VSV G transmembraue  domain. This oligonucle- 
otide, s'CC.  CAA. AGT. CGG. GTG.  ACC. TCT. ArT. GCC  y, is sense 
strand sequence and encodes QSRVTSIA, where T is amino acid 239 of the 
v-sis protein, and the second S residue is amino acid 464 of VSV G. The 
other two oligonucleotides  encompassed the extreme 3' coding region of the 
v-sisZS9-G gene including extra sequences  encoding a functional or non- 
functional ER retention signal  followed by an XhoI site for cloning pur- 
poses.  The oligonucleotide  encoding the functional ER retention signal, 
YGC~CCTCGAG.  TTA. GC__~. CAT. TIT. TTT. CTC. GTC. CTT. TCC. 
AAG. ICG. GTT. CAT. CTC. TAT  y, is antisense sequence and encodes 
the amino acid sequence IEMNRLGKDEKKMP-term in the sense strand. 
The  oligonucleotide  encoding  the  nonfunctional ER  retention signal, 
5'GCd2CCTCGAG. TTA. TTT. TTT. GC_KL CAT. CTC. GTC. CTT. TCC. 
AAG. TCG.  GTT. CAT. CTC.  TAT  s', is also antisense sequence and en- 
codes IEMNRLGKDEMPKK-term in the sense strand. PCR was used to 
amplify appropriate DNA fragments using the v-sis239-G gene as a tem- 
plate. PCR amplified products were cleaved with BstEII and Xhol, purified, 
and ligated  into a BstEII/XhoI cleaved plasmid containing the v-sis2~-G 
geue to create the fusions v-sis239-G-ER  + and v-sis239-G-ER  -  (Fig.  1 B). 
The v-sis239-G-ER  + protein contains the functional ER retention signal, 
while the v-sis2Sg-G-ER  - protein contains the nonfunctional mutant signal. 
Appropriate addition of sequences  encoding the two  hexapeptides  was 
confirmed  by  DNA  sequencing.  DNA  fragments encoding  v-sis2S9-G, 
v-sis239-G-ER  +, and v-sis239-G-ER  -  were subsequently cloned into retro- 
viral expression vectors for transfection into NIH 3T3 ceils (see below). 
Mutation of the dibasic proteolytic processing site of the v-sis protein from 
Lys I ~O_ArgH  l to Asn  II~  n  has previously been reported (Hannink and 
Donoghue, 1986b).  Sequences  encoding this mutation were swapped into 
v-sis expression vectors using standard molecular cloning techniques. 
Focus Formation Assay and Expression of 
v-sis Proteins 
Genes encoding the membrane-anchored v-sis fusion proteins depicted in 
Fig.  1 B were placed under control of the Molony routine leukemia virus 
(M-MuLV) long terminal repeat in the retroviral expression vector, pDD102 
(Bold and Donoghue,  1985). For focus assays, NIH 3T3 cells were trans- 
fected with these expression plasmids in the presence of a replication com- 
petent helper provirus, pZAP (Hoffman et al., 1982), using a modified cal- 
cium phosphate transfection protocol (Chen and Okayama,  1987). Briefly, 
2  x  105 cells were split onto 60-mm dishes and the following day trans- 
fected with a mixture of 50 ng expression plasmid, 50 ng pZAP, 0.5 ~g 
pRSVneo,  and 9.4 t~g carrier plasmid DNA.  Cells were incubated with 
precipitate overnight, refed,  and split the following day  1:4 onto 100-mm 
dishes. Half the cells were scored for focus formation after 5 d and the other 
half selected  in (3418 (400 p.g/ml) for 10 d, after which time transfection 
efficiency was compared by scoring G418 resistant colonies. 
To obtain pools of cells expressing the various v-sis fusion proteins, 
transfections were carried out as described above,  except larger relative 
amounts of each plasmid were used (8 ~g expression plasmid, 1 ~g pZAP, 
and 1 ~g pRSVneo). Infected virus-producing pools of cells resulting from 
(3418 selection were carried in culture for extended periods of time, up to 
10 wk, and used for immunofluorescence,  metabolic labeling, and in vitro 
kinase assays.  >80% of G418 resistant cells expressed the various  fusion 
proteins as determined try immunofluorescence  analysis. 
Indirect Immunofluorescence 
To detect only intracellular v-sis fusion proteins, cells were fixed in 3 % 
paraformaldehyde/PBS  for 10 rain, followed by permeabilization in 1% Tri- 
tordPBS for 5  min. Cells were then incubated with a  rabbit antiserum 
directed against the v-s/s protein, followed by a rhodamine-conjugated goat 
anti-rabbit antibody. To detect both intracellular and cell surface expressed 
v-sis fusion proteins, cells were fixed with paraformaldehyde,  and treated 
with the v-sis protein antibody  before permeabilization. Cells were then per- 
meabilized and treated with 10 #g/ml of a mAb directed against the COOH 
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Figure L Membrane-anchored 
v-sis fusion proteins. A depicts 
the membrane orientation of 
various v-sis proteins as well 
as  two  other growth  factors, 
CSF-1 and SCF, known to ex- 
ist as membrane-anchored pre- 
cursors. SCF is also known as 
mast cell growth factor, and is 
the ligand for the kit receptor. 
B shows a more detailed repre- 
sentation of various v-sis fu- 
sion proteins.  The v-sis239-G 
fusion was constructed by com- 
bining sequences encoding the 
first  239  amino acids  of the 
v-sis protein  with  sequences 
encoding the COOH-terminal 
49 amino acids of the VSV G 
protein (Hannink and Donog- 
hue,  1986a).  The  v-sis239-G - 
ER  +  and  v-sis239-G-ER  -  fu- 
sions contain COOH-terminal 
hexapeptides defined as a func- 
tional (DEKKMP)  or mutant 
(DEMPKK) ER retention sig- 
nal (Nilssanet al., 1989). Other 
significant features shown in- 
clude:  a  signal  sequence  for 
secretion; an N-linked oligo- 
saccharide addition site; and a 
dibasic proteolytic processing 
site  (Lysll~  Also  in- 
dicated are the v-sis nummal 
transforming region (M/R, en- 
closed by the dotted lines) as 
well  as  the  transmembrane 
and cytoplasmic domains from 
VSV G. 
terminus of the VSV G protein. Cell surface expressed v-sis fusion proteins 
were detected with a rhodamine-conjugated  goat anti-rabbit  antibody, while 
intracellular v-sis fusion proteins were detected  with a biotin-conjugated 
goat anti-mouse antibody,  followed by FITC-conjugated  streptavidin. 
Metabolic Labeling and Immunoprecipitations 
NIH 3T3 cells expressing various v-sis fusion proteins were obtained as de- 
scribed above. Cells were split 5 x  l0  s on 60-ram plates and the following 
day rinsed and incubated for 15 min in MEM lacking cysteine and methio- 
nine. For the glycosidase  digestion experiment, cells were labeled for 3 h 
with 200 #Ci/ml each [35S]cysteine and [35S]methionine in MEM lacking 
cysteine and methionine. For pulse-chase analyses,  cells were labeled with 
150 #Ci/ml each [35S]cysteine and [3SS]methionine for 30 rain,  rinsed 
twice with TBS, and chased for various times in fresh DME. Labeled cells 
were subsequently lysed in 1.0 ml radioimmunoprecipitation assay (RIPA) 
buffer (10 mM sodium phosphate, pH 7.0, 150 mM NaCI,  1% NP-40,  1% 
sodium deoxycholate,  0.1% SDS,  1% Aprotinin) and clarified  lysates in- 
cubated for 2 h with either a goat antibody directed against human PDGF- 
AB or a rabbit antibody directed against the murine PDGF ~5 receptor.  Im- 
mune complexes were isolated with either rabbit anti-goat IgG coupled to 
agarose  beads or with Protein A-Sepharose (Sigma  Chemical Co.,  St. 
Louis,  MO).  For  oligosaccharide  analysis,  immunoprecipitates  were 
digested  with endoglycosidase  H,  neuraminidase, and O-glycosidase  (all 
from Boehfinger Mannheim Corp., Indianapolis, IN) as described previ- 
ously (Daniel et al.,  1987).  Immunoprecipitates were subsequently  ana- 
lyzed by SDS-PAGE and detected by fluorography. 
Suramin Treatment and In Vitro Kinase Assays 
NIH 3"1"3 cells expressing  various v-sis fusion proteins were split 5  ￿  105 
cells per  100-ram  plate.  The following  day, medium was  removed  and 
replaced with DME containing 10% CS with or without 100/~M suramin. 
Cells were examined  for morphological  changes after 24 h in suramin. 
For in vitro kinase analysis,  cells were split 5  ￿  105 per 60-mm plate 
and the following day serum starved for 24 h in DME containing 0.5% CS 
with or without 100 #M suramin. Following serum starvation, cells were 
left untreated or incubated with 100 ng/ml PDGF-BB (Arngen,  Thousand 
Oaks, CA) at 37"C for 5 min, after which cells were lysed in 1 rnl NP-40 
lysis buffer (20 mM Tris, pH 7.4, 137 mM NaCI,  1% NP-40, 1 mM sodium 
and Donoghue ER-retained v-sis Protein  1059 orthovanadate,  5  mM EDTA,  1 mM  PMSE  10 /zg/ml Aprotinin,  10% 
glycerol)  on ice for 10 min. Cell  lysates  were  scraped from plates and 
clarified for 10 rain in a microcentrifuge  to remove cellular debris. Clarified 
lysates were incubated for 2 h with a rabbit antiserum directed against the 
human PDGF ~  receptor and immune complexes  isolated  with Protein 
A-Sepharose. Immunoprecipitates were washed twice in NP-40 lysis buffer 
and once in 20 mM Tris, pH 7.4. Washed complexes were resuspended  in 
40/~1 kinase (20 mM Tris, pH 7.4, 10 mM MnC12, 5 mM MgCI2) contain- 
ing 5 ttCi .y32p ATP and incubated at 37~  for 10 min followed by 7.5% 
SDS-PAGE and autoradiography. 
Results 
Membrane-anchored v-sis b'hsion Proteins 
A biologically active form of the v-sis protein, v-sis239-G, is 
anchored to the cell membrane via the transmembrane do- 
main of the VSV G and has been described previously (Han- 
nink and Donoghue, 1986a). Although PDGF has not been 
found as a naturally occurring transmembrane growth factor, 
macrophage colony stimulating factor (CSF-1) and stem cell 
factor (SCF) do exist in transmembrane forms and the recep- 
tors for these growth factors are  members of the PDGF 
receptor family (Rettenmier et al.,  1987; Anderson et al., 
1990).  Thus, the study of v-sis239-G may serve as a model 
system  for  understanding  how  these  naturally  occurring 
membrane-anchored  growth  factors  function.  The  mem- 
brane orientation of v-sis239-G as well as CSF-1 and SCF is 
depicted in Fig.  1 A. Also depicted are v-sis  ~ and the ER- 
retained form of v-sis239-G described below. 
The v-sis239-G protein contains the first 239 amino acids 
of the v-sis protein fused to the COOH-terminal 49 amino 
acids of VSV G (Fig.  1 B). The v-sis portion of the v-sis239-G 
fusion contributes: (a) a signal sequence for secretion; (b) 
the propeptide region containing a  single site for N-linked 
oligosaccharide addition; (c) the dibasic proteolytic process- 
ing site (LysH0-Arg~"); and (d) sequences which encompass 
the minimal transforming region (MTR) of v-sis (Hannink 
et al., 1986; Sauer et al., 1986; King et al., 1985). The VSV 
G portion of the fusion contributes the transmembrane do- 
main and COOH-terminal cytoplasmic tail of the protein. 
Upon synthesis in mammalian cells, the v-sis239-G protein 
enters the secretory pathway where it undergoes signal se- 
quence  cleavage,  N-linked  oligosaccharide addition,  and 
protein  dimerization.  Following its transport  through the 
Golgi complex, the protein is subsequently proteolyzed at 
the dibasic processing site to yield the mature membrane- 
anchored form of the v-sis protein. This protein retains the 
ability to  interact productively with  PDGF  receptors  as 
demonstrated by its ability to efficiently transform NIH 3T3 
ceils (Hannink and Donoghue,  1986a).  Surprisingly, how- 
ever, no autophosphorylation of PDGF receptors is detected 
in  response  to  mitogenically active  v-sis239-G  (Lee  and 
Donoghue, 1991). 
To address the question of whether cell surface expression 
of v-sis protein is required for efficient transformation of 
NIH 3T3  cells, the v-sis239-G protein was retained within 
the cell and prevented from reaching the cell surface. This 
was accomplished by appending a signal for ER retention 
onto the COOH terminus of v-sis239-G and subsequently ex- 
amining the effects of intracellular retention on biological 
transformation. A  hexapeptide sequence (DEKKMP), de- 
scribed as an ER retention signal for the adenoviral trans- 
membrane protein E3/19K (Nilsson et al.,  1989),  was ap- 
pended to the COOH terminus of the v-sis239-G protein to 
create v-sis239-G-ER+ (Fig.  1 B). As a control, a permuted 
mutant signal (DEMPKK) was also added to the COOH ter- 
minus ofv-sis239-G  to create v-sis239-G-ER - (Fig. 1 B). This 
mutant signal does not function as an ER retention signal 
(Nilsson et al.,  1989). 
ER Retention Signal Prevents Cell Surface Expression 
of  Membrane-anchored v-sis Protein 
The  v-sis239-G-ER+ and  v-sis:39-G-ER -  proteins  were  ex- 
pressed in NIH 3T3 cells using a M-MuLV-based retroviral 
expression vector (Bold and Donoghue, 1985) and the sub- 
cellular localization of the proteins examined by indirect im- 
munofluorescence using an antibody directed  against the 
v-sis protein. As shown in Fig. 2, the v-sis239-G-ER+ protein 
accumulated to much higher levels within cells (Fig. 2 A) 
when compared with the v-sis239-G-ER-  protein (Fig.  2 B). 
More  reticular  staining  was  visible  in  cells  expressing 
v-sis239-G-ER  +, while distinct Golgi-staining was observed 
in cells expressing v-sis239-G-ER -.  This pattern of expres- 
sion is consistent with the v-sis239-G-ER + protein being re- 
tained in the ER and the v-sisn~-G-ER- protein being trans- 
ported beyond the ER, through the Golgi complex, and to 
the cell surface. Untransfected NIH 3T3 cells did not exhibit 
any specific staining using the antibody directed against the 
v-sis protein (data not shown). 
To examine whether these v-sis fusion proteins were being 
transported to the plasma membrane,  a  double-label  im- 
munofluorescence experiment was performed. An antibody 
that recognizes the COOH terminus of the VSV  G protein 
was used to visualize intracellular fusion proteins, while an 
antibody directed against the v-sis protein was used to exam- 
ine fusion proteins expressed on the cell surface. To detect 
cell surface v-sis proteins with the v-sis protein antibody, it 
was necessary to use fusions that had the dibasic proteolytic 
processing site mutated from Lys"~  ~H to Asn~~ 
This mutation prevents proteolytic maturation of v-sis, but 
has no effect on the transforming ability of the protein (Han- 
nink  and  Donoghue,  1986a,b).  This  manipulation  was 
necessary  since  the  v-sis  protein  antibody preferentially 
recognizes a determinant within the propeptide of v-sis (our 
own unpublished observation), and this determinant is miss- 
ing in mature proteins  expressed on the cell surface.  As 
shown in Fig.  3,  external staining of cells expressing the 
AsnH~  mutants of v-sis239-G (Fig. 3 A) and v-sis239-G  - 
ER- (Fig. 3 E) showed a general overall fluorescence pat- 
tern indicative of proteins expressed on the cell surface. 
However, little or no cell surface fluorescence was observed 
for cells expressing the  AsnH0-SerH~ mutant of v-sis239-G  - 
ER  + (Fig.  3 C), even though this protein was still being ex- 
pressed intracellularly (Fig. 3 D).  Untransfected NIH 3T3 
cells did not exhibit specific staining using either the v-sis 
protein antibody or the antibody directed against the COOH 
terminus of VSV G (data not shown). These results indicate 
that appending an ER retention signal onto the COOH termi- 
nus of v-sis239-G results in intracellular retention of the pro- 
tein and an inhibition of detectable cell surface expression. 
ER Retention Signal Prevents Proteolytic Maturation 
of  Membrane-anchored v-sis Protein 
The v-sis protein undergoes several posttranslational modi- 
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lation  of  membrane-anchored 
v-sis protein containing an ER 
retention signal. Indirect immu- 
nofluorescence was  performed 
on permeabilized NIH 3T3 ceils 
expressing  v-sis239-G-ER +  (A) 
or v-sis239-G-ER -  (B).  Fusion 
proteins were detected using a 
rabbit  serum  directed  against 
the  v-sis protein followed by a 
rhodamine-conjugated  goat anti- 
rabbit IgG. Note the increased 
reticular staining visible in cells 
of A compared with B. 
fications during its transport through the secretory pathway. 
One  of  these,  an  NH2-terminal  proteolytic  processing 
event,  is  believed to  occur late  in  the  secretory pathway 
somewhere between the trans-Golgi compartment and plasma 
membrane (Robbins et al.,  1985; Lokeshwar et al.,  1990). 
If the  v-sis239-G-ER +  protein  is  retained  in  the  ER  and 
prevented from reaching later compartments of  the secretory 
pathway, differences should be observed in the extent of pro- 
teolytic maturation of v-sis239-G-ER § compared to v-sis239-G 
and v-sis239-G-ER -.  The extent of NH2-terminal proteolytic 
processing was examined by immunoprecipitation using an 
antibody directed against human PDGF-AB. This antibody 
recognizes both the full length and mature form of the v-sis 
protein. Immunoprecipitates were also treated with various 
glycosidases to examine oligosaccharide content. As shown 
in Fig. 4, protein doublets of"o  23 kD (Fig. 4, arrow 3) were 
detected  from  cells  expressing  v-sis239-G  and  v-sis239-G - 
ER-, but were absent from cells expressing v-sis239-G-ER § 
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prevents cell  surface expres- 
sion  of  membrane-anchored 
v-sis protein. Cell surface and 
intracellular  v-sis  proteins 
were examined using double- 
label immunofluorescence as 
described  in  Materials  and 
Methods.  The  extracellular 
domain of various fusion pro- 
teins  was  detected  using  a 
rabbit serum directed against 
the  v-sis  protein.  The intra- 
cellular  domain  of  the  fu- 
sion  proteins  was  detected 
using a mouse mAb directed 
against  the  COOH-terminus 
of the VSV G protein. (A and 
B)  v-sis239NS-G; (C  and  D) 
v-sis239NS-G-ER+; (E  and  F) 
v-sis239NS-G-ER-.  A,  C,  and 
E are cell surface staining. B, 
D,  and  F  are  intracellular 
staining.  "NS"  indicates  the 
Asnn~  mutation  of the 
Lyslt~  m  processing  site, 
resulting in an uncleared pro- 
peptide and increased irnmu- 
nofluorescent detection using 
the v-sis protein antibody. 
These protein doublets were the predicted size for the pro- 
teolytically processed  mature  fusion  proteins.  Thus,  the 
v-sis239-G-ER + protein did not appear to be proteolyzed to 
the mature form. The heterogeneity in size observed for the 
processed mature proteins was likely due to differences in 
O-linked glycosylation, since treatment with both neuramin- 
idase and O-glycosidase slightly shifted the mobility of these 
proteins. The mobility shift seen after O-glycosidase treat- 
ment was not as pronounced as that seen after neuraminidase 
treatment,  but it is  real and experimentally reproducible. 
When immunoprecipitates were treated with  endoglycosi- 
dase H, which cleaves high mannose N-linked oligosaccha- 
ride, mobility shifts occurred from 33-kD proteins (Fig. 4, 
arrow 1) to 30-kD proteins (Fig. 4, arrow 2). This indicates 
that the  33-kD  proteins  contain N-linked oligosaccharide 
and correspond to full length v-sis fusion proteins. Failure 
of  the 33-kD proteins to be modified by either neuraminidase 
or O-glycosidase indicates that proteolytic processing oc- 
curs before the addition of sialic acid and O-linked oligo- 
saccharides. This implies that sialic acid and O-linked oligo- 
saccharide  additions  occur  in  a  post-Golgi  compartment 
of the  secretory pathway,  since  previous studies  have 1o- 
calized  the  v-sis  proteolytic processing  event to  a  post- 
Golgi  compartment  (Lokeshwar et  al.,  1990;  Robbins  et 
al.,  1985).  This should not be surprising,  since glycosyl- 
transferases have been detected in a  variety of post-Golgi 
compartments (Taatjes et al., 1988), and evidence does exist 
for extra-Golgi or cell surface localized glycosyltransferases 
(Shur,  1982). 
In addition to the above mentioned experiment which de- 
tects  steady-state levels of v-sis  fusion proteins,  a  pulse- 
chase analysis was performed to examine the conversion of 
full length v-sis fusion proteins to the corresponding mature 
forms. The turnover of full length v-sis fusions was used as 
a measure of the rate of proteolytic processing. As shown in 
Fig. 5, the full length v-sis239-G and v-sis239-G-ER - proteins 
turned over and were converted to mature proteins with half- 
times of ',,1.5 h,  while the v-sis239-G-ER + protein showed 
little detectable conversion to mature protein  after a  3-h 
chase. Further analysis with chase times out to 24 h detected 
a very small amount (<5 % conversion) of mature v-sis  239- 
G-ER  § protein (data not shown),  indicating a  slight leaki- 
ness in the ER retention system of these cells. Nonetheless, 
these  data  indicate that  v-sisZ39-G-ER §  is  overwhelmingly 
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prevents  proteolytic maturation 
of membrane-anchored  v-sis 
protein.  Equivalent  numbers 
(5  ￿  105) of NIH 3T3 cells 
expressing various v-sis fusion 
proteins  were  labeled  with 
[35S]cysteine and  [35S]methi- 
onine for 3 h and immunopre- 
cipitated  with  an  antiserum 
directed against human PDGF- 
AB. Immunoprecipitated pro- 
reins were left untreated (-) 
or digested with endoglycosi- 
dase H (H), O-glycosidase  (O), 
or neuraminidase  (N), and sub- 
sequenfly  analyzed  by  15% 
SDS-PAGE followed by fluo- 
rography.  Molecular  mass 
markers in kilodaltons are in- 
dicated at the left. Numbered 
arrows indicate the following 
proteins:  1,  full  length v-sis 
fusion  proteins  containing 
N-linked oligosaccharide;  2, 
full  length  v-sis  fusion  pro- 
reins  lacking  N-linked 
oligosaccharide; 3, proteolyti- 
cally  processed  v-sis  fusion 
proteins.  Exposure  time was 
2 wk. 
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Figure 5.  "Ihrnover of full length membrane-anchored v-sis pro- 
reins. NIH 3"1"3  cells expressing various v-sis fusion proteins were 
pulse labeled  for 30 rain with  [3~S]cysteine  and [35S]methionine 
and chased for 0, 1, 2, and 3 h. v-sis fusion proteins were immuno- 
precipitated  with an antibody directed against human PDGF-AB 
and analyzed by SDS-PAGE  and detected by fluorography. Relative 
protein level was determined by densitometric scanning of protein 
retained in the ER with little transport to the trans-Golgi net- 
work where proteolytic maturation of  v-sis protein is thought 
to occur. 
ER-retained v-sis Protein Exhibits Reduced 
Transforming Activity 
The effect of ER localization on the transforming activity of 
membrane-anchored v-sis protein was examined by assaying 
the ability of v-sis239-G-ER  + to  induce focus formation in 
NIH 3T3 cells. The v-sis fusions depicted in Fig.  1 B were 
expressed in NIH 3T3 cells using a  M-MuLV-based retro- 
viral vector and a replication competent helper provirus to 
provide viral spread (Bold and Donoghue, 1985; Hoffman et 
al.,  1982). As shown in Table I and Fig. 6, the v-sis239-G- 
ER  + protein was inhibited in its ability to transform NIH 
3T3 cells. The v-sis239-G-ER+  protein induced 10-fold fewer 
loci (Table I), which were also much smaller in size (Fig. 6 
D) when compared with v-sis  w' (Fig.  6  B),  v-sis239-G  (Fig. 
6  C),  and v-sis239-G-ER  -  (Fig.  6 E).  The foci induced by 
v-sis  w'  were much  larger and  diffuse compared with  foci 
induced by membrane-anchored v-sis proteins. This was pre- 
sumably due to secretion of v-sis  ~  protein and its growth- 
bands corresponding to each full length v-sis fusion protein and 
plotted against time to examine protein turnover. (-c~-)  v-sis239-G; 
(-0-) v-sis239-G-ER+; (.~-) v-sis239-G-ER  -. 
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v-sis Fusions 
Relative 
v-sis  transforming 
Fusion  Focus assay  activity 
FFU/pmol  Percent v-sis  ~ 
mock  0  0 
v-sis "~ (secreted)  3.7  x  l&  100 
v-sis239-G  3.4  x  104  92 
v-sis239-G-ER  +  3.4  x  103  9.2 
v-sis2~-G-ER-  3.3  x  104  89 
v-s/s fusions were assayed for focus-forming  activity as described in Materials 
and Methods. Results from a typical focus assay are presented and represent 
the average from two experiments. Focus assay results are given in focus- 
forming units per pmol of plasmid DNA transfected (FFU/pmol). 
promoting effect on neighboring cells. Similar results were 
also obtained with the corresponding AsnHo-Serm process- 
ing site mutants (data not shown), confirming that propep- 
tide cleavage is not required for efficient transformation of 
NIH 3"1"3  cells. The reduced level of  transformation exhibited 
by v-sis239-G-ER  + demonstrates that inefficient transforma- 
tion results when an otherwise fully transforming v-sis pro- 
tein is retained in the ER. 
The residual foci observed for v-sis239-G-ER  + most likely 
result from leaky retention in a subpopulation of cells which 
fail  to  retain  the  protein  and  therefore  transport  small 
amounts beyond the ER. The possibility of leaky retention 
is supported by the extended pulse-chase analysis mentioned 
earlier in which production of a  small amount of mature 
v-sis239-G-ER  § protein was noted after a 24-h chase. Leaky 
retention is  also  supported by the  following observation. 
When pools of cells expressing the v-sis239-G-ER  + protein 
were carried in culture for an extended period of time (>6 
wk), the cells gradually acquired a transformed morphology 
which eventually become indistinguishable from cells ex- 
pressing v-sis239-G or v-sis239-G-ER-.  This was due to selec- 
tion of a population of cells exhibiting leaky retention of the 
v-sis239-G-ER  + protein. In cells carried for 8 wk in culture, 
transport  of  v-sis239-G-ER  + protein  beyond  the  ER  was 
noted and confirmed by detection of significant amounts of 
proteolytically processed protein (Fig.  7,  lane 3),  while a 
newly established pool  of v-sis239-G-ER  + expressing cells 
showed no detectable proteolytic processing (Fig. 7, lane 5). 
Thus, a correlation exists between the appearance of proteo- 
lytically processed v-sis239-G-ER  + protein and the acquisi- 
tion of  the transformed phenotype. These results suggest that 
efficient transformation requires the transport of membrane- 
anchored v-sis protein beyond the ER, possibly up to or past 
the site where proteolytic maturation occurs. 
ER-retained v-sis Protein Does Not Downregulate 
PDGF f3 Receptors 
Cell surface PDGF receptors are normally downregulated in 
ceils transformed by the v-sis  ~  protein. This is because of 
chronic interaction of  v-sis protein with PDGF receptors fol- 
lowed  by  internalization  and  degradation  via  receptor- 
mediated endocytosis.  The  ability of various membrane- 
anchored v-sis proteins to downregulate PDGF 13 receptors 
was examined by measuring the level of cell surface activata- 
ble receptors and also by examining receptor turnover by 
Figure  6.  Focus-formation assay. Representative samples from a 
focus assay were photographed after fixing in methanol and subse- 
quent  staining with  0.4% Giemsa in  100  mM  Tris, pH  6.8, 
methanol. 
pulse-chase analysis. Activatable cell surface receptors were 
examined by PDGF-BB treatment of serum-starved cells, 
followed by  PDGF  receptor  immunoprecipitation and  in 
vitro kinase analysis. As shown in Fig. 8, cells expressing 
transforming v-sis proteins  (v-sis  "~,  v-sis239-G  and  v-sis  239- 
G-ER-) all showed reduced levels of cell surface activatable 
receptors (Fig. 8, lanes 10, 11, and 13 respectively). An 8-wk 
culture of cells expressing the v-sis239-G-ER  + protein also 
showed reduced levels of  activatable receptors, '~10-fold less 
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numbers (5  x  10  5 of NIH 3T3 cells expressing various v-sis pro- 
teins were labeled for 2.5 h with 200 #Ci/ml  each [35S]cysteine 
and [35S]methionine. Cell lysates were immunoprecipitated with 
an antibody directed against human PDGF-AB and analyzed by 
15 % SDS-PAGE  followed  by fluorography. The arrow indicates the 
position of proteolytically processed v-sis fusion proteins. Molec- 
ular mass markers in kilodaltons are indicated at the left. Lane 1, 
mock; lane 2, v-sis239-G; lane 3, v-sis239-G-ER  + from cells carried 
in culture for 8 wk; lane 4, v-sis239-G-ER-;  and lane 5, v-sis239-G - 
ER  +. Comparison of lanes 3 and 5 indicates that ceils expressing 
v-sis239-G-ER + exhibit detectable proteolytic processing in trans- 
formed ceils passaged for 8 wks. Exposure time was 3 d. 
compared with mock-infected cells (Fig. 8, lanes 9 and 12). 
However,  a  newly  established  pool  of  cells  expressing 
v-sis239-G-ER  + exhibited levels of activatable receptors com- 
parable with mock-infected ceils (Fig.  8, lanes 9 and 14). 
These results indicate that the v-sis239-G-ER  + protein cannot 
downregulate PDGF/3 receptors when efficiently retained in 
the  ER.  Receptor  downregulation  does  occur,  however, 
when the v-sis239-G-ER  + protein is transported beyond the 
ER as with cells carded in culture for 8 wk. 
Turnover of mature PDGF/3 receptors was also examined 
by pulse-chase analysis. As seen in Fig. 9, when compared 
with mock-infected NIH 3T3 cells, cells expressing v-sis  ~ 
exhibited rapid turnover of PDGF/3 receptors, while cells 
expressing  v-sis239-G-ER  +  did  not.  For  cells  expressing 
v-sis239-G or v-sis239-G-ER  -, an intermediate rate of receptor 
turnover was observed indicating that these fusion proteins 
still induced receptor turnover, but did so less efficiently  than 
secreted v-sis  ~  protein. This slower rate of receptor turn- 
over was likely the result of steric constraints placed upon 
the protein by its membrane anchor. These results indicate 
that membrane-anchored v-sis protein, when transported be- 
yond the ER, can interact with PDGF/3 receptors and in- 
crease receptor turnover, albeit not as efficiently as secreted 
v-sis  ~  protein. 
Suramin  Reverts  Transformation  and  Upregulates 
PDGF  [3 Receptors 
Suramin is a polyanionic compound that has been reported 
to inhibit PDGF mitogenic activity and to revert the v-sis 
transformed phenotype (Betsholtz et al.,  1986). Suramin is 
believed to exert this effect by disrupting receptor-ligand in- 
teractions at the cell surface as indicated by the ability of sur- 
amin to reduce the level of tyrosine-phosphorylated cell sur- 
face  PDGF  receptors,  while  not  affecting  the  level  of 
intracellular tyrosine-phosphorylated receptors (Fleming et 
al., 1989). However, since suramin also reaches intraceilular 
sites,  notably lysosomes at high concentrations (Hawking, 
1978; La Rocca et al., 1990), it has been postulated that sur- 
amin  may disrupt  intracellular  interactions between  v-sis 
protein and  PDGF  receptors  (Huang  and  Huang,  1988). 
Nevertheless, the work of Fleming et al. (1989) strongly in- 
dicates an extracellular site of action for suramin in the dis- 
ruption of v-sis/PDGF receptor interactions. 
Fig.  10 shows the effect of suramin on the morphology of 
various cell pools. Suramin reverted the transformed pheno- 
type of cells expressing v-sis  ~  (Fig.  10 F),  v-sis239-G (Fig. 
10 H) and v-sis239-G-ER  -  (Fig.  10 J), but had no effect on 
the morphology of cells transformed by a non-growth fac- 
tor-related  oncogene,  v-mos  (Fig.  10  L).  Suramin  also 
reverted the transformed morphology of v-sis239-G-ER+ ex- 
pressing cells that had been carried in culture for over 8 wk 
(data  not  shown),  consistent with  transport of v-sis239-G  - 
ER  + to a suramin-sensitive location. Suramin had no obvi- 
ous effect on the morphology of early passage cells express- 
ing v-sis239-G-ER  § (Fig.  10 D). 
The effect of suramin  on the expression of cell surface 
PDGF/3 receptors was also examined by in vitro kinase anal- 
ysis. As described previously, activatable cell surface recep- 
tors were examined by PDGF-BB treatment of serum-starved 
cells, followed by PDGF receptor immunoprecipitation and 
in vitro kinase analysis. As shown in Fig.  11, suramin treat- 
ment  led  to  the  upregulation  of activatable  cell  surface 
PDGF/3 receptors in cells expressing v-sis  "~, v-sis239-G, and 
v-sis239-G-ER  -  (Fig.  11,  lanes  7,  8,  and  10,  respectively). 
These results are consistent with suramin disrupting recep- 
tor-ligand interactions at the cell surface. In summary, these 
experiments suggest that there is  an essential cell surface 
component to membrane-anchored v-sis transformation. 
Discussion 
Results presented in  this report demonstrate that addition 
of an  ER  retention  signal  onto  the  COOH  terminus  of 
Lee and Donoghue  ER-retained v-sis Protein  1065 Figure 8. In vitro kinase anal- 
ysis  of cell surface  PDGF/3 
receptors.  Equivalent  num- 
bers  (5  x  105  of NIH  3T3 
cells expressing  various  v-sis 
proteins  were  serum-starved 
for 24 h in DME containing 
0.5% FCS. After serum star- 
vation, cells  were  either left 
untreated or treated  with  100 
ng/ml PDGF-BB for 5 min at 
370C.  PDGF receptors  were 
subsequently immunoprecipi- 
tated and subjected to in vitro 
kinase assay  as  described  in 
Materials and Methods. 32p-la- 
beled PDGF/3 receptors were 
detected  by  SDS-PAGE  and 
autoradiography.  The  arrow 
indicates  the  position of the 
cell surface PDGF/3 receptor. 
Molecular  mass  markers  in 
kilodaltons  are  indicated  at 
the left.  (Lanes 1 and 8) un- 
transfected  NIH  3T3  cells; 
lanes 2  and  9,  mock  trans- 
fected NIH 3T3 cells; lanes 3 
and I0, v-sis't; lanes 4 and 11, 
v-sis239-G; lanes  5  and  12, 
v-sis239-G-ER +  from  ceils 
carried  in culture for  8  wk; 
lanes  6  and  13,  v-sis239-G- 
ER-,  and lanes 7 and 14,  v- 
sis239-G-ER  + from early pas- 
sage cells. Exposure time was 
3h. 
Figure 9. Turnover  of PDGF 
receptors.  Equivalent  num- 
bers  (5  x  105  )  of NIH 3T3 
cells expressing  various  v-sis 
proteins  were  pulse  labeled 
for  30  min  with  [35S]cys- 
teine and [35S]methionine and 
chased  for 0,  1,  2,  and 3 h. 
Cell lysates were immunopre- 
cipitated with an antibody di- 
rected  against  the  murine 
PDGF  /3  receptor  and  ana- 
lyzed by 7.5 % SDS-PAGE fol- 
lowed  by  fluorography.  (A) 
Relative  receptor  level  was 
determined by  densitometric 
scanning  of protein bands cor- 
responding  to  the  mature 
PDGF/3 receptor (pl80)  and 
plotted  against  time  to  ex- 
amine  receptor turnover. (-o-) 
mock;  (--~-)  v-siswt;  (-A.-) 
v-sis239-G;  (-42-)  v-sis239-G - 
ER+;  (-e-)  v-sis239-G-ER -. 
(B)  The arrow  indicates  the 
position of the mature PDGF 
/3  receptor.  Molecular  mass 
markers in ldlodaltons are in- 
dicated  at the left.  Exposure 
time was 6 d. Figure 10.  Suramin reversion 
of membrane-anchored  v-sis 
transformation. NIH 3T3 cells 
expressing various v-sis pro- 
reins were treated with I00/~M 
suramin for 24 h at which time 
cell  morphology  was  exam- 
ined and compared with un- 
treated  cells.  Representative 
photomicrographs  are  pre- 
sented. 
v-sis239-G results  in  intracellular  retention  and  inhibited 
proteolytic processing of the protein. This ER-retained pro- 
tein exhibited reduced transforming activity and was unable 
to downregulate PDGF ~ receptors. Acquisition of the trans- 
formed phenotype correlated with transport of the protein 
beyond the ER to a site where proteolytic processing can oc- 
cur. Finally, suramin treatment reverted transformation and 
upregulated cell surface PDGF j3 receptors. These results in- 
dicate that productive receptor-ligand interactions do not 
occur in the ER and suggest that signal-transducing interac- 
tions occur post-ER, most likely at the cell surface. 
Previous Evidence Supporting 
"lntracrine" Interactions 
The question of where productive receptor-ligand interac- 
tions take place in v-sis-transformed cells has been the sub- 
ject of some debate.  In v-sis-transformed  cells, both v-sis 
protein and  PDGF  receptors are  synthesized through the 
secretory pathway,  and therefore the opportunity exists for 
growth factor-receptor interactions within the cell, as well 
as at the cell surface. Keating and Williams (1988) have de- 
tected activated receptors within intracellular compartments 
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sponse to suramin.  Equivalent numbers (5  x  105) of NIH 31"3 
cells expressing various v-sis proteins were serum-starved for 24 h 
in 0.5% CS or 0.5% CS containing  100/~M suramin.  After se- 
rum starvation, cells were incubated with 100 ng/ml PDGF-BB for 
5 min at 37"C. PDGF receptor immunoprecipitates were subse- 
quently analyzed for in vitro kinase activity as described in Materi- 
als and Methods. 32p-labeled PDGF/~ receptors were detected by 
SDS-PAGE and autoradiography. The arrow indicates the position 
of  the mature cell surface PDGF/3 receptor. Molecular mass mark- 
ers in kilodaltons are indicated at the left. Lanes 1 and 6, mock 
transfected NIH 3T3 cells; lanes 2 and 7, v-sis~; lanes 3 and 8, 
v-sis239-G; lanes 4  and  9,  v-sis239-G-ER  +,  and  lanes 5  and  10, 
v-sis239-G-ER  -. 
of SSV-transformed NRK cells. The majority of these recep- 
tors did not reach the cell surface and had altered processing 
compared with receptors stimulated by exogenous PDGE 
Huang and co-workers demonstrated similar results in that 
most  newly  synthesized  PDGF  receptors  in  SSV-trans- 
formed cells were not detected at the cell surface and ex- 
hibited rapid  turnover because of intracellular interaction 
with v-sis protein possibly within the ER and/or Golgi com- 
plex (Huang and  Huang,  1988;  Lokeshwar et al.,  1990). 
Rapid turnover of v-sis protein was also noted and intracellu- 
lar forms of the protein were shown to be mitogenic. These 
observations complemented the work of Keating and Wil- 
liams (1988) and suggested that intracellular receptor activa- 
tion, termed "intracrine" activation, was sufficient for auto- 
trine transformation by v-sis. 
Bejcek et al.  (1989) have also addressed the question of 
where productive receptor-ligand interactions occur by ap- 
pending  an  ER  retention signal  for luminal  ER  proteins 
(KDEL) onto the COOH terminus of a  normally secreted 
v-sis protein.  This v-sis-KDEL fusion was not detectably 
secreted into the medium and was assumed to be retained in 
the ER.  When assayed for transforming ability, the v-sis- 
KDEL fusion was just as active as the secreted v-sis protein, 
implying that intracelhlar interactions were sufficient for 
autocrine stimulation of growth. At the time this experiment 
was  performed, the available evidence suggested that the 
KDEL retention signal provided for efficient retention in the 
ER.  However, subsequent work has shown that the KDEL 
retention signal retards, but does not prevent, the secretion 
of fusion proteins containing the signal (Zagouras and Rose, 
1989). Thus, another interpretation of the results of Bejcek 
et al.  (1989) would be that sufficient v-sis-KDEL protein 
reached the cell surface, resulting in morphological transfor- 
marion, but that the fusion protein was rapidly internalized 
via receptor-mediated endocytosis and thus not detectably 
secreted. 
Previous Evidence Supporting a Post-Golgi or Cell 
Surface Site for Productive Interactions 
Hannink and Donoghue (1988), using an inducible autocrine 
system, have also examined the site of productive interaction 
by blocking cell surface transport of newly synthesized v-sis 
protein using the carboxylic ionophore monensin. Monensin 
blocks the transport of secretory proteins through the trans- 
Golgi complex (Tartakoff, 1983) and was shown to prevent 
both autophosphorylation of cell surface PDGF receptors 
and expression of c-fos in response to induced intracellular 
synthesis of v-sis protein. Monensin did not, however, pre- 
vent autophosphorylation of an intracellular ER-Golgi form 
of the receptor, indicating that signal transduction can be 
blocked even in the presence of activated intracellular recep- 
tors. It is important to note that the observation of internally 
activated PDGF receptors in this study is consistent with the 
work of Keating and Williams (1988), and Huang and Huang 
(1988), but this study additionally suggests that transport of 
v-sis protein to a compartment past the site of monensin ac- 
tion (i.e., the trans-Golgi  complex or beyond) is required to 
functionally couple activated PDGF receptors to growth sig- 
nalling pathways. 
Fleming  et  al.  (1989)  have  also  addressed  the  site  of 
productive interaction by  examining  autocrine-stimulated 
PDGF receptors in the presence of suramin.  Suramin was 
shown to completly block the proliferation of v-sis-trans- 
formed ceils and to markedly reduce the level of tyrosine- 
phosphorylated cell surface receptors.  This treatment did 
not,  however,  affect  the  level  of  intracellular  tyrosine- 
phosphorylated receptors, suggesting that the PDGF recep- 
tor species relevant to fibroblast transformation was an acti- 
vated receptor-ligand complex located at the cell surface. 
These results are consistent with the work of Hannink and 
Donoghue (1988) described above, which identifies the loca- 
tion  of autocrine  signalling  as  being  beyond  the  site  of 
monensin action, i.e., in the trans-Golgi  network or at the 
cell surface. 
Autocrine Signal Transduction Requires v-sis Protein 
Transport Beyond the ER 
In this report, we have examined the site of productive auto- 
crine interactions by preventing cell surface expression of a 
membrane-anchored v-sis protein using the ER retention sig- 
nal from the adenoviral transmembrane protein E3/19K. ER 
retention of  this protein led to inefficient  cellular transforma- 
tion, in contrast to the results of Bejcek et al. (1989). These 
contradictory results may be because of differences in how 
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retention provided by each signal. As mentioned earlier, it 
has since been shown that the KDEL retention signal retards, 
but does not prevent, secretion of fusion proteins containing 
the signal (Zasgouras and Rose, 1989). It is also possible that 
the cytoplasmically located E3/19K retention system exerts 
tighter control over retention, or may be less easily satura- 
ble, compared with the luminal KDEL retention system. 
Our data demonstrate that transformation by membrane- 
anchored v-sis is not completely inhibited by addition of an 
ER retention signal. There is, however, a significant  decrease 
in the number and size of loci formed. The residual transfor- 
mation  observed  for  v-sis239-G-ER §  is  likely  because  of 
leaky retention in a  subpopulation of cells which fail to 
efficiently localize the protein to the ER. Failure to localize 
this protein in the ER may result from saturation of the reten- 
tion system in cells which overexpress the protein, or may 
result from a subpopulation of cells which exhibit defective 
retention.  A  leaky  retention  system  would  allow  some 
v-sis239-G-ER + protein to be transported past the ER to a 
site where growth signalling interactions can occur. This ex- 
planation for residual transformation is consistent with the 
ability to select, during 8 wk in culture, for a transformed 
population of cells which was able to proteolytically process 
v-sis239-G-ER + protein and which exhibited downregulated 
PDGF/~ receptors. The detection of significant amounts of 
proteolytically processed  v-sis239-G-ER + protein  (Fig.  7, 
lane 3)  indicated efficient transport of this protein to the 
trans-Golgi  network,  since proteolytic maturation of v-sis 
protein is known to occur in a post-Golgi compartment of  the 
secretory pathway (Robbins et al.,  1985;  Lokeshwar et al., 
1990).  The escape of v-sis239-G-ER + protein from the ER 
might also have occurred by selection for cells expressing 
mutant forms of v-sis239-G-ER + lacking a retention signal. 
The appearance of proteins with altered molecular weight 
would have supported this model. However, as shown in Fig. 
7,  and  also  in  several  additional  experiments  (data  not 
shown), we have seen no evidence that continued passage of 
cells  selected  for  the  expression  of truncated  forms  of 
v-siF39-G-ER  +. 
Where Do Productive Receptor-Ligand Interactions 
Occur in the v-sis Autocrine System ? 
Our results suggest that membrane-anchored v-sis protein 
cannot productively interact with PDGF receptors in the ER. 
Productive interactions must therefore occur post-ER, either 
in the Golgi, trans-Golgi network, or at the cell surface. It 
is  possible  that  interactions  between  growth  factor  and 
receptor still occur in the ER, but that receptor-mediated en- 
docytosis and transmission of autocrine growth signals can- 
not occur until the complex is transported beyond the ER. 
This  is  consistent with  our  observation that transport of 
v-sis239-G-ER + past the ER correlated with acquisition of 
the transformed phenotype and the ability to downregulate 
PDGF  receptors.  It  would  be  informative to  determine 
whether ER-retained v-sis protein can activate PDGF recep- 
tors within the ER. However, since the membrane-anchored 
v-sis protein does not induce PDGF receptor autophosphor- 
ylation (Lee and Donoghue, 1991), activated receptors can- 
not be examined directly. 
The  previously  mentioned  results  from  Hannink  and 
Donoghue (1988)  demonstrate that monensin blocks v-sis 
autocrine signal transduction and  suggest that productive 
receptor-ligand  interactions  occur  in  or  past  the  trans- 
Golgi. Our observation demonstrating that acquisition of the 
transformed phenotype correlated  with transport  of v-sis 
protein beyond the Golgi, to the site where proteolytic pro- 
cessing occurs, also supports a potential post-Golgi site for 
autocrine  signal  transducing  interactions.  These  results 
taken together suggest that productive autocrine interactions 
may occur in the trans-Golgi network or at the cell surface. 
Results demonstrating that suramin can revert transforma- 
tion by membrane-anchored v-sis indicate that productive 
receptor-ligand interactions occur at a site sensitive to the 
action of suramin. As mentioned above, the exact site of sur- 
amin action is not completely clear,  however,  strong evi- 
dence exists indicating that suramin may act by disrupting 
activated  receptor-ligand  complexes  at  the  cell  surface 
(Fleming et al.,  1989).  In our report we demonstrate that 
suramin reverts  membrane-anchored  v-sis  transformation 
and upregulates the expression of cell surface PDGF recep- 
tors.  This is consistent with the disruption of cell surface 
receptor-ligand interactions. However,  it is also consistent 
with the disruption of intracellular receptor-ligand interac- 
tions followed by transport of unoccupied receptors to the 
cell surface. If suramin has an exclusive extracellular site of 
action, these results would indicate that productive growth 
signalling interactions are limited to the cell surface. How- 
ever,  since suramin is known to have intracellular effects 
(Hawking,  1978;  La Rocca et al.,  1990),  we cannot com- 
pletely rule out the possibility that some component of  trans- 
formation may be  because  of internally activated PDGF 
receptors. 
Implications for Perturbing Autocrine 
Signal Transduction 
Determining the  site where productive autocrine interac- 
tions occur has implications for the design and use of ther- 
apeutic agents employed in the treatment of human cancers 
which involve autocrine loops.  Tumor cells which exhibit 
productive  intracellular  interactions  would  not  likely be 
treatable with antagonists whose action is limited to the cell 
surface. However, if productive autocrine interactions occur 
exclusively at the cell surface, then autocrine transformed 
cells may be amenable to treatment with exogenous antago- 
nists. The results presented in this paper as well as those of 
Fleming et al. (1989), suggest an important cell surface com- 
ponent to autocrine transformation by v-sis. Therefore, an- 
tagonists of ligand-receptor complex formation, such as sur- 
amin or future drugs exhibiting greater specificity, offer hope 
for the efficient perturbation of autocrine signal transduction 
loops. 
In conclusion, our results indicate that productive auto- 
crine  interactions between membrane-anchored v-sis  and 
PDGF receptors occur post-ER. Our results are consistent 
with  productive  interactions  occurring  in  a  post-Golgi, 
suramin-sensitive location, most likely at the cell surface. 
Cell surface expression of activated receptor/ligand com- 
plexes may be required for efficient signal transduction in the 
event that key intermediates involved in this process are also 
localized to the cell surface. 
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